CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Black Diamond Therapeutics, Inc. (BDTX) on Thursday reported a loss of $18.2 million in its first quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 35 cents.
The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 44 cents per share.
Black Diamond shares have more than doubled since the beginning of the year. The stock has more than tripled in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BDTX at https://www.zacks.com/ap/BDTX
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
